TrialCancer medicine2020

Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma.

Dongbin Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.